BioVentures, LLC
USPTO PatentsView assignee record - 79 granted patents across 34 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Bioventures ranks #4,455 of 49,997 tracked US assignees by granted-patent volume, with 79 patents across 34 technology areas.
- #4,455
- of 49,997 US assignees by volume
- Top 12%
- by Innovation Score (50.9/100)
- 14.2
- avg claims per patent
- +43%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4455 · US Corporation #4,455 · 79 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 79 grants
- TOP-DECILE #4,455/49,997
- PHOTO-FINISH Aeris Communications
- CPC-FOCUS A61K · 34 areas
- INNOV-PAR 50.9/100
- CLAIMS-RICH 14.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +43% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Aeris Communications, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Bioventures’s 50.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Bioventures
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- BioVentures · this assignee
BioVentures · this assignee
51 score
- Dispensing Dynamics… · near
Dispensing Dynamics… · near
51 score
- McAlister · near
McAlister · near
51 score
- Ojjo · near
Ojjo · near
51 score
- Taiyo Nippon Sanso · near
Taiyo Nippon Sanso · near
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Bioventures's Innovation Score is 50.9/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Bioventures?
Each dot is one of Bioventures’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioventures’s own 14.2 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Bioventures's grants concentrate
BioVentures, LLC is a focused PatentsView assignee: 34 CPC subclasses with 53.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (14 grants) versus a trough of 1 in 2015. By volume, Bioventures sits between Aeris Communications, Inc. and Corning Precision Materials Co., Ltd..
Bioventures's three-year grant acceleration
From 2019–2021 to 2022–2024, BioVentures, LLC moved from 26 to 26 grants (1.00x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at BioVentures's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aeris Communicati…
Aeris Communications, Inc.
79 patents
- Aptargroup
AptarGroup, Inc.
79 patents
- Audible
Audible, Inc.
79 patents
- Biocatch
Biocatch Ltd.
79 patents
- Checkpoint Systems
Checkpoint Systems, Inc.
79 patents
- Csem Centre Suiss…
Csem Centre Suisse D'electronique ET DE Microtechnique SA—RECHERCHE ET DÉVELOPPEMENT
79 patents
- Cadila Healthcare
Cadila Healthcare Ltd.
79 patents
- Corning Precision…
Corning Precision Materials Co., Ltd.
79 patents
- Bioventures ◀
BioVentures, LLC
79 patents
What this shows BioVentures holds 79 patents at rank #4,455, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near BioVentures
By rank, the assignees closest to #4,455 in granted patent volume.
- Aeris Communications, Inc. #4,451 · 79 patents
- AptarGroup, Inc. #4,452 · 79 patents
- Audible, Inc. #4,453 · 79 patents
- Biocatch Ltd. #4,454 · 79 patents
- Checkpoint Systems, Inc. #4,456 · 79 patents
- Csem Centre Suisse D'electronique ET DE Microtechnique SA—RECHERCHE ET DÉVELOPPEMENT #4,457 · 79 patents
- Cadila Healthcare Ltd. #4,458 · 79 patents
- Corning Precision Materials Co., Ltd. #4,459 · 79 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in BioVentures's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for BioVentures, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), BioVentures ranks #535 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (51 here).
Similar claim depth
Nearest assignees by average claims per patent (14.2 here).
Bioventures's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.3% |
| 2017 | 6 | 7.6% |
| 2018 | 14 | 17.7% |
| 2019 | 9 | 11.4% |
| 2020 | 11 | 13.9% |
| 2021 | 6 | 7.6% |
| 2022 | 10 | 12.7% |
| 2023 | 7 | 8.9% |
| 2024 | 9 | 11.4% |
| 2025partial year | 6 | 7.6% |
Which technologies does BioVentures, LLC patent most?
Top 15 of 34 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
BioVentures, LLC's patent record in context - here's where to go next.
- BioVentures, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 53.2% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #4,455 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare BioVentures, LLC against Aeris Communications, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.